Search PubMed⌕ Search

Biomedical subjects

J D Perry

Publications and source records attributed to J D Perry.

105 records · Page 6Linked to original sources

Increased responsiveness of rheumatoid B lymphocytes to stimulation by Epstein-Barr virus.

Blood lymphocytes from rheumatoid patients and normal subjects were examined for responsiveness in culture to Epstein-Barr virus (EBV) infection by outgrowth assay and 3HTdR uptake. With both unseparated and B-cell-enriched lymphocytes the frequency and rate of outgrowth to form permanent cell lines were significantly higher for rheumatoid than for normal cells. In B-enriched rheumatoid preparations the proportion of responsive cells was also greater, and DNA synthesis was induced by a lower infecting dose of EBV in rheumatoid than in normal cells. The percentage of autologous T cells needed to ensure regression of B-cell proliferation in EBV-infected cultures was considerably higher with rheumatoid than with normal cells. These findings suggest that in rheumatoid arthritis the abnormal lymphocyte responsiveness to EBV has two components, a T-cell immunoregulatory defect, and a separate increased responsiveness of B cells to EBV.

Antibodies, Monoclonal↗

Remedial therapy after stroke: a randomised controlled trial.

Of 1094 patients with a confirmed stroke admitted to Northwick Park, a district general hospital, 364 (33%) died while in hospital, 215 (20%) were fully recovered when discharged, and 329 (30%) were too frail or too ill from diseases other than stroke to be considered for active rehabilitation. Only 121 (11%) were suitable for intensive treatment. They and 12 patients referred direct to outpatients were allocated at random to one of three different courses of rehabilitation. Intensive was compared with conventional rehabilitation and with a third regimen which included no routine rehabilitation, but under which patients were encouraged to continue with exercises taught while in hospital and were regularly seen at home by a health visitor. Progress at three months and 12 months was measured by an index of activities of daily living. Improvement was greatest in those receiving intensive treatment, intermediate in those receiving conventional treatment, and least in those receiving no routine treatment. Decreasing intensity of treatment was associated with a significant increase in the proportions of patients who deteriorated and in the extent to which they deteriorated. Probably only a few stroke patients, mostly men, are suitable for intensive outpatient rehabilitation, but for those patients the treatment is effective and realistic.

Activities of Daily Living↗

Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis.

Without prior knowledge of the diagnosis or clinical status, sera from patients with various arthritides were screened for antibody against rheumatoid-arthritis-associated nuclear antigen (RANA) with indirect immunofluorescence on cytocentrifuged Raji cell preparations. 93% of 103 seropositive rheumatoid patients had anti-RANA antibody, in contrast to 16% of 50 normal controls and a mean of 19% (10-29%) of 122 patients with other arthritides. Anti-RANA antibody was also demonstrated in 95% of 21 patients with seronegative rheumatoid arthritis characterised by symmetrical erosive peripheral polyarthritis. No correlation was found in rheumatoid arthritis between anti-RANA antibody and disease activity, duration of disease, drug therapy, or extra-articular manifestations. RANA staining was absent in a non-Epstein-Barr-virus (EBV) cell line (Ramos). In 10 rheumatoid patients, discordance between the presence of antibodies to EBV antigens (viral capsid antigen [VCA] and EBNA) ANd RANA antibody was demonstrated. Anti-RANA antibody could be a useful marker for rheumatoid arthritis.

Antibodies, Antinuclear↗

Ankylosing hyperostosis: a study of HLA A, B, and C antigens.

HLA A, B, and C antigens were studied in 25 patients with ankylosing hyperostosis. There was no evidence of an increased frequency of any antigen in association with the condition itself. However, a high frequency of several antigens was found, reflecting the predominance of Jewish patients in the series.

Ankylosis↗

Diclofenac sodium (Voltarol) and indomethacin: a multicentre comparative study in rheumatoid arthritis and osteoarthritis.

A five-centre double-blind crossover trial of two two-week periods using diclofenac and indomethacin showed that both drug groups (51 patients) with rheumatoid arthritis responded similarly in relation to pain scores and morning stiffness. It was noted that the response was better in inpatients than in outpatients, despite differences in disease severity. In the osteoarthritis trial (58 patients) it was shown that neither drug significantly reduced resting pain, although both drugs were significantly better in reducing pain on movement; however, patient preference was for diclofenac. Three patients treated with indomethacin withdrew owing to side-effects, compared with one on diclofenac. A slight but significant decrease in haemoglobin levels was observed in both treatment groups with osteoarthritis, but this did not appear to be symptom-related.

Arthritis, Rheumatoid↗

Electrophoretic behaviour of blood and synovial fluid lymphocytes in rheumatoid arthritis.

Probit analysis of the electrophoretic mobilities of human blood lymphocytes identifies at least three main subpopulations. According to their rate of movement in an electrical field, the subpopulations are referred to as the fast, intermediate and slow cell distributions. Lymphocytes of the fast and intermediate populations appear to be T cells, while the slow cell population includes cells with B cell characteristics. Compared with normal subjects, lymphocytes of intermediate mobility are significantly increased in the blood of rheumatoid patients and comprise a major fraction of the lymphocyte exudate in rheumatoid synovial fluid.

Arthritis, Rheumatoid↗

Brief assessments of dietary behavior in field settings.

Our research team is involved in ongoing research in both worksites and medical office settings. These settings offer great potential for reaching individuals who would not otherwise participate in health promotion, but they also place considerable constraints on assessment time and efforts, especially if one's goal is to attract a high and representative proportion of employees or patients. This paper reports on our experience with measures of dietary behavior in these two settings. We found it problematic to collect detailed assessments such as 4-day food records or comprehensive food frequency/history checklists in worksites or medical office settings using population-based samples. Instead, we recommend and provide data on the utility of a dietary-fat screening instrument, and on the Food Habits Questionnaire (FHQ-Kristal, Shattuck, & Henry, 1990), a brief measure of dietary behaviors associated with high-fat eating patterns. The FHQ, in particular, was found to correlate well with other more costly and time-consuming methods of assessment, to be reliable and responsive to intervention effects, and to provide behavioral targets for intervention. The strengths and limitations of these measures for tailoring intervention and assessing outcomes are discussed.

Adult↗

Olfactory detection thresholds using pyridine, thiophene, and phenethyl alcohol.

An objective examination of olfactory function is needed for evaluation and clinical progression of patients with olfactory deficits. Two hundred sixty-eight healthy subjects were studied in order to establish olfactory thresholds for three test odorants. Subjects were required to simply detect the presence of an odor when comparing various log dilutions of test odorant against two "blank flasks. These data have provided a means of quantitating existing olfactory deficits in affected patients. Olfactory function was found to be diminished in elderly subjects and should be considered a factor when evaluating older patients.

Adolescent↗